These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19921629)

  • 1. [Treatment of drooling with botulinum toxin type A in cerebral palsy].
    Duarte CS; Alves TR; Azeredo PM; Almeida SI
    Rev Neurol; 2009 Dec 1-15; 49(11):610. PubMed ID: 19921629
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and duration of botulinum toxin treatment for drooling in 131 children.
    Scheffer AR; Erasmus C; van Hulst K; van Limbeek J; Jongerius PH; van den Hoogen FJ
    Arch Otolaryngol Head Neck Surg; 2010 Sep; 136(9):873-7. PubMed ID: 20855679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.
    Jongerius PH; van den Hoogen FJ; van Limbeek J; Gabreëls FJ; van Hulst K; Rotteveel JJ
    Pediatrics; 2004 Sep; 114(3):620-7. PubMed ID: 15342830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Botulinum toxin treatment of spastic cerebral palsy].
    Hansen LK; Pedersen NR; Westphall IT; Pedersen LT; Jensen H; Villads A
    Ugeskr Laeger; 2004 Aug; 166(34):2888-90. PubMed ID: 15449526
    [No Abstract]   [Full Text] [Related]  

  • 5. Is injection of botulinum toxin type A effective in the treatment of drooling in children with cerebral palsy?
    Vaile L; Finlay F
    Arch Dis Child; 2006 Oct; 91(10):862-3. PubMed ID: 16990361
    [No Abstract]   [Full Text] [Related]  

  • 6. Botulinum toxin type A and dynamic equinus in children with cerebral palsy: new indication. Better than repeat casts.
    Prescrire Int; 2001 Feb; 10(51):12-4. PubMed ID: 11503850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin A injection for children with spastic cerebral palsy.
    YaJie W; BaoQin G
    Dev Med Child Neurol; 2008 Aug; 50(8):640. PubMed ID: 18754907
    [No Abstract]   [Full Text] [Related]  

  • 8. Ultrasound-guided submandibular gland injection of botulinum toxin for hypersalivation in cerebral palsy.
    Sriskandan N; Moody A; Howlett DC
    Br J Oral Maxillofac Surg; 2010 Jan; 48(1):58-60. PubMed ID: 19371986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.
    Banerjee KJ; Glasson C; O'Flaherty SJ
    Dev Med Child Neurol; 2006 Nov; 48(11):883-7. PubMed ID: 17044954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why do children with cerebral palsy discontinue therapy with botulinum toxin A?
    Weigl DM; Arbel N
    Dev Med Child Neurol; 2007 Feb; 49(2):159-60. PubMed ID: 17297747
    [No Abstract]   [Full Text] [Related]  

  • 11. Correspondence on ''Outcome measures used in studies of botulinum toxin in childhood cerebral palsy: a systematic review''.
    Bares M; Minks E; Husárová I; Ferencová K
    J Child Neurol; 2010 Jun; 25(6):793-4; author reply 794. PubMed ID: 20508237
    [No Abstract]   [Full Text] [Related]  

  • 12. The expanding role of botulinum toxin type A injections in the management of children with cerebral palsy.
    Carr LJ
    Dev Med Child Neurol; 2009 Sep; 51(9):687-8. PubMed ID: 19709139
    [No Abstract]   [Full Text] [Related]  

  • 13. Does botulinum toxin prevent or promote deformity in children with cerebral palsy?
    Gough M
    Dev Med Child Neurol; 2009 Feb; 51(2):89-90. PubMed ID: 19191839
    [No Abstract]   [Full Text] [Related]  

  • 14. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
    Dai AI; Wasay M; Awan S
    J Child Neurol; 2008 Dec; 23(12):1464-6. PubMed ID: 19073853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Why do children with cerebral palsy discontinue therapy with botulinum toxin A?'.
    Linder-Lucht M; Kirschner J; Herrmann J; Geth K; Korinthenberg R; Berweck S; Heinen F; Mall V
    Dev Med Child Neurol; 2006 Apr; 48(4):319-20. PubMed ID: 16542523
    [No Abstract]   [Full Text] [Related]  

  • 16. Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy.
    Lundy CT; Doherty GM; Fairhurst CB
    Dev Med Child Neurol; 2009 Sep; 51(9):705-10. PubMed ID: 19459910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin type A in the treatment of sialorrhea in Parkinson's disease.
    Melo A; Rodrigues B; Nóbrega AC
    J Am Geriatr Soc; 2009 Jan; 57(1):180; author reply 180-1. PubMed ID: 19170803
    [No Abstract]   [Full Text] [Related]  

  • 18. Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study.
    Lagalla G; Millevolte M; Capecci M; Provinciali L; Ceravolo MG
    Mov Disord; 2006 May; 21(5):704-7. PubMed ID: 16440332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type A for the treatment of the spastic equinus foot in cerebral palsy.
    Cardoso ES; Rodrigues BM; Barroso M; Menezes CJ; Lucena RS; Nora DB; Melo A
    Pediatr Neurol; 2006 Feb; 34(2):106-9. PubMed ID: 16458821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of sedation using nitrous oxide compared with enteral midazolam for botulinum toxin A injections in children.
    Kumar R; Sneade C; Littler K
    Dev Med Child Neurol; 2009 Oct; 51(10):838-9. PubMed ID: 19747281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.